Journal of Pharmacoeconomics and Pharmaceutical Management، جلد ۱، شماره ۳/۴، صفحات ۵۹-۶۰
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Prior authorization by the Health Insurance Organizations in Iran
چکیده انگلیسی مقاله Background: Health care improvement has had a critical role in increasing life expectancy throughout the world. The expenditures of research and development and also marketing for new pharmaceutical products are much higher than already existing medicines, resulting in higher prices for the former products. Therefore governments and health insurance organizations are interested in implementing policies that control drug prescription and utilization. One of these policies is Prior Authorization (PA). The main goal of PA is to reduce drug expenditures by substituting expensive medicines with less costly ones. PA policy has both scientific and economical aspects. The aim of this article is to assess the state of implementation of PA policy in Iran. There are several bodies to regulate medicines and their price in Iranian pharmaceutical market. There are two main insurance companies in Iran with similarities and differences in implementing this policy. Price ceiling and Reference Based Pricing are two main methods for implementing PA policy in Iran.
کلیدواژه‌های انگلیسی مقاله
نویسندگان مقاله | Mehrnaz Kheirandish
Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.


| Zahra Gharibnaseri
Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.


| Fatemeh Soleymani
Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy and Pharmaceutical policy research center, Tehran University of Medical Sciences (TUMS), Tehran, Iran.


| Abbas Kebriaeezadeh
Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran AND Department of Pharmacoeconomics and Pharmaceutical Management, Faculty of Pharmacy and Pharmaceutical policy research center, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
نشانی اینترنتی http://jppm.tums.ac.ir/index.php/jppm/article/view/14
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/2743/article-2743-2050441.pdf
کد مقاله (doi)
زبان مقاله منتشر شده
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات